My research focuses on improving the prevention, diagnosis, and control of HIV and sexually transmitted infections (STIs) through epidemiology, surveillance, and implementation science.
I use large-scale clinical and surveillance datasets to evaluate population-level trends, assess the impact of public health interventions, and generate evidence to inform policy and practice.
My work sits at the intersection of:
Epidemiology and biostatistics
Real-world data and surveillance systems
Implementation science and health systems
Public health policy and translation
View a list of my publications here
HIV & STI prevention
Evaluation of biomedical prevention strategies, including HIV pre-exposure prophylaxis (PrEP) and doxycycline post-exposure prophylaxis (doxyPEP)
Population-level impacts of prevention scale-up
Behavioural and clinical outcomes associated with prevention use
Surveillance and epidemiology
Use of large-scale sentinel surveillance systems (e.g. ACCESS)
Trends in HIV, syphilis, gonorrhoea, and other STIs
Real-world epidemiological analyses to inform national monitoring
Implementation science
Translation of evidence into clinical practice and policy
Evaluation of models of care for prevention and testing
Measuring acceptability, feasibility, and real-world effectiveness
Diagnostic innovation and self-testing
Development and evaluation of novel STI diagnostics
Implementation of syphilis self-testing (ITEST Study)
Exploring new pathways for testing outside traditional clinical settings
A hybrid effectiveness–implementation trial evaluating the acceptability, feasibility, and real-world implementation of syphilis self-testing among priority populations.
Focus areas:
Models of care and service delivery
Linkage to care following self-testing
Integration with online distribution platforms
Research examining uptake, adherence, and population-level impact of doxycycline post-exposure prophylaxis for STI prevention.
Includes:
Real-world cohort studies
Population-level analyses using surveillance data
Policy-relevant evaluation of prescribing strategies
Use of national sentinel surveillance data to:
Monitor STI trends and testing patterns
Evaluate intervention impacts (e.g. PrEP, COVID disruptions)
Inform public health guidelines and policy
Evaluation of implementation of long-acting injectable therapies, including:
Acceptability and appropriateness in clinical settings
Patient and healthcare worker experiences
Real-world delivery models
Thesis: Epidemiology and Prevention of Sexually Transmissible Infections among Gay and Bisexual Men in the Era of HIV Pre-exposure Prophylaxis
Supervisors: Prof. Mark Stoové, Prof. Margaret Hellard, Prof. Edwina Wright
Monash Univeristy, 2022
A full list of conference presentations and abstracts is available here: